Category: Cancer Treatment
Oceania Cancer Treatment
-
Clinical Decision Support System Market Research Report Information by Component (Software, Services, and Hardware) By Product (Integrated CDSS and Standalone CDSS), By Model (Knowledge-Based CDSS and Non-Knowledge-Based CDSS), By Delivery Mode (On-Premise CDSS and Cloud-Based CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced Clinical Decision Support Systems and Conventional Clinical Decision Support Systems), By Region (North America, Europe, Asia-Pacific, and Rest of the World) - Industry Forecast till 2032
... CDSS), By Mode of Advice (Active CDSS and Passive CDSS), By Setting (Inpatient Settings and Ambulatory Care Settings) By Type (Therapeutic Clinical Decision Support Systems and Diagnostic Clinical Decision Support Systems ), By Application (Advanced ... Read More
-
Biologics Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Monooclonal Antibodies, Vaccines, Recombinant Hormones/Proteins, Cell and Gene Therapy, and Others), Application (Cancer, Infectius Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, Autoimmune Diseases, and Others), Source (Mammalian and Microbial), Manufacturing (Outsourced and In-house), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) According to our new research study ... Read More
-
Nuclear Medicine Market Research Report Information by Type (Diagnosis [SPECT Radiopharmaceuticals {Tc99m, I-123, and Others} and PET Radiopharmaceuticals {F18, C11 Choline, and Others}] and Therapeutic (Alpha Emitters [Actinium-225 (Ac-225), Radium-223 (Ra-223), and Others], Beta Emitters [Yttrium-90 (Y-90), Lutetium-177 (Lu-177), and Others], and Brachytherapy Isotopes [Iodine-125 (I-125) and Others]), by Application (Neurology, Cardiology, Oncology [Prostate Cancer, Breast Cancer, Lung and Bronchus Cancer, Thyroid Cancer, Colorectal Cancer, and Others], and Others), by End User (Hospitals & Diagnostic Centers, Research Institutes, and Others), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) – Industry Forecast till 2032
... [Yttrium-90 (Y-90), Lutetium-177 (Lu-177), and Others], and Brachytherapy Isotopes [Iodine-125 (I-125) and Others]), by Application (Neurology, Cardiology, Oncology [Prostate Cancer, Breast Cancer, Lung and Bronchus Cancer, Thyroid Cancer, Colorectal Cancer, and Others], and Others), by ... Read More
-
Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) Chronic pain is defined as any pain lasting for more ... Read More
-
Global Cancer Therapeutics And Biotherapeutics Market, By Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head and Neck Cancer, Giloblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others), By Therapy Type (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research Institutes, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... Targeted Therapy, Immunotherapy, Radiation Therapy, Hormone Therapy, Biotherapy, and Others), By Application (Therapeutics, Drug Discovery, Gene therapy, IVF treatment, Cell therapy, and Research & Development), By End User (Hospitals & Clinics, Cancer Care Centers, Research ... Read More
-
2024 What's Next for Australia Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for 500 ... Read More
-
2024 What's Next for New Zealand Diagnostics Market? - Supplier Shares and Strategies, 2023-2028 Volume and Sales Forecasts for 500 Tests - Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM
... Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM This new report from LeadingMarketResearch.com provides granular analysis of the diagnostic testing market, including 2023 supplier shares, strategies, as well as 2023-2028 volume and sales forecasts for ... Read More
-
2024 New Zealand Nucleic Acid Testing (NAT) Market Opportunities - Competitive Shares and Growth Strategies, 2023-2028 Volume and Sales Segment Forecasts for 100 Infectious, Genetic, Cancer, Forensic and Paternity Tests - Latest Technologies and Instrumentation Pipeline, Market Barriers and Risks
... Pipeline, Market Barriers and Risks This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the molecular diagnostics market during the next five years. ... Read More
-
2024 Australia Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barriers
... is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as forensic and paternity/HLA testing during the ... Read More
-
2024 New Zealand Genetic Diseases, Cancer, Forensic, Paternity Molecular Diagnostics Market Opportunities - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation Pipeline, Market Barrier
... report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities for molecular diagnostic technologies and products for diagnosing genetic diseases, cancer, as well as forensic and paternity/HLA testing during ... Read More
-
2024 Australia Molecular Diagnostics Market: 2023 Supplier Shares, Instrumentation Installed Base and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products for ... Read More
-
2024 New Zealand Molecular Diagnostics Market: 2023 Supplier Shares, Instrumentation Installed Base and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... 2023 supplier shares, the 2023-2028 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing new technologies and products ... Read More
-
2024 Asia-Pacific Immunodiagnostics Market Database for 18 Countries - 2023 Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests
... provides information and analysis not available from any other published source . This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein ... Read More
-
2024 Australia Immunodiagnostics Market Database - 2023 Supplier Shares, 2023-2028 Volume and Sales Segment Forecasts for 100 Abused Drugs, Cancer, Clinical Chemistry, Endocrine, Immunoprotein and TDM Tests
... analysis not available from any other published source . This database from LeadingMarketResearch.com provides the 2023 supplier shares, the 2023-2028 volume and sales forecasts for 100 clinical chemistry, TDM, endocrine, cancer, immunoprotein and abused drug ... Read More
-
2024 New Zealand Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Instrumentation Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging ... Read More
-
2024 Australia Tumor Markers Testing Market - High-Growth Opportunities for Cancer Diagnostic Tests and Analyzers - 2023 Supplier Shares and Strategies, 2023-2028 Volume and Sales Segment Forecasts for Major Tumor Markers, Latest Technologies and Instrumentation Pipeline, Emerging Opportunities for Suppliers
... Pipeline, Emerging Opportunities for Suppliers This new report from LeadingMarketResearch.com provides a strategic analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines emerging trends ... Read More
-
Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Vectors (Non-Viral Vectors and Viral Vectors), Indication (Neurological Diseases, Cancer, Duchenne Muscular Dystrophy, Hepatological Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... Diseases, and Other Indications), Delivery Mode (In-Vivo and Ex-Vivo), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) The gene therapy market size is expected to grow from ... Read More
-
Asia-Pacific MRD Testing Market: Analysis and Forecast, 2023-2033
... CAGR of 16.06% during the forecast period 2023-2033. The MRD testing market is expanding due to several reasons, including the expansion of Medicare coverage for MRD testing and its application in diagnosing solid tumors. Increased ... Read More
-
Australia and New Zealand Cutaneous T-cell Lymphoma Market Report and Forecast 2024-2032
... and New Zealand cutaneous T-cell lymphoma market size is anticipated to grow at a CAGR of 11.3% during the forecast period of 2024-2032, driven by the increasing prevalence of the condition and the development of ... Read More
-
Asia-Pacific EV-Based Liquid Biopsy Market: Analysis and Forecast, 2023-2032
... at a CAGR of 21.64% during the forecast period. The market for EV-based liquid biopsy is anticipated to see growth propelled by continuous technological progress, rising acceptance by healthcare providers, and an increasing emphasis on ... Read More
-
Non-muscle Invasive Bladder Cancer Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middl
... and Africa) The global non-muscle invasive bladder cancer therapeutics market reached a valuation of US$ 2.8 billion in 2024. The market is forecasted to progress to reach US$ 9.2 billion by the end of 2031. ... Read More
-
Progressive Multifocal Leukoencephalopathy Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and
... Africa) The global progressive multifocal leukoencephalopathy treatment market is set to experience steady growth from 2024 to 2031. Several key insights are driving this growth in the market: Factors Driving Market Growth: • Rising HIV ... Read More
-
Asia Pacific Fluorescence In-Situ Hybridization (Fish) Imaging Systems Market Forecast to 2030 – Regional Analysis – By Product (Instruments, Consumables, Accessories, and Software), Application (Cancer Diagnosis, Genetic Disease Diagnosis, Infectious Disease Diagnostic, and Others), and End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others)
... End User (Diagnostic Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnological Companies, and Others) The Asia Pacific fluorescence in-situ hybridization (FISH) imaging systems market is expected to grow from US$ 217.6 million in 2022 to US$ ... Read More
-
Immuno-Oncology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... relentless global health challenge, is the second-leading cause of death worldwide, following cardiovascular disease. According to the World Health Organization (WHO), an estimated 8.3 million lives are claimed by cancer annually, with approximately 70% of ... Read More
-
Breast Tissue Markers Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... The global breast tissue markers market witnessed revenue of $2.9 billion in 2024 and is poised to attain a market value of $6.1 billion by the end of 2031, as reported in a recent market ... Read More